Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs
Stockchase Opinions

Jim Cramer - Mad MoneyInovio PharmaceuticalsINODON'T BUYApr 28, 2021

It's a spec stock that hasn't delivered.
$7.06

Stock price when the opinion was issued

$1.10

As of Jun 12, 2026. Market Open.

Pharma & Healthcare
It's the ideal tool to help you make quicker, more informed decisions for managing and tracking your investments.

You might be interested:

COMMENT

It is too small and volatile.

RISKY
A smaller pharma name. It's a pure spec stock. If you're a young investor, it doesn't hurt to hold one spec stock.